Showing 12,901 - 12,920 results of 46,952 for search '(( 50 ((a decrease) OR (teer decrease)) ) OR ( 5 ((wt decrease) OR (mean decrease)) ))', query time: 0.84s Refine Results
  1. 12901

    Comorbidity pattern of patients. by Tamrat Petros Elias (18536434)

    Published 2024
    “…Finally, 340 were included in the study. The majority (68.5%) were males and the mean age was 53.9 (±13.3 SD) years. …”
  2. 12902

    Patient selection for this study. by Tamrat Petros Elias (18536434)

    Published 2024
    “…Finally, 340 were included in the study. The majority (68.5%) were males and the mean age was 53.9 (±13.3 SD) years. …”
  3. 12903

    The pulmonary hemodynamics and the fluctuation in the serum antibody levels against EXD2 and PHAX peptides in patients with CTEPH before and one year after pulmonary endarterectomy... by Akira Naito (663843)

    Published 2019
    “…<p>The mean pulmonary artery pressure decreased from 45.5±10.9 to 25.3±7.4 mmHg and the pulmonary vascular resistance decreaseased from 732.0±287.4 to 322.1±157.2 dyne·sec·cm<sup>-5</sup>. …”
  4. 12904

    Activation of deep SC neurons recapitulates delayed LER in <i>Setd5</i><sup><i>+/−</i></sup> animals. by Laura E. Burnett (18794525)

    Published 2024
    “…(<b>I</b>) Proportion of trials at different laser intensities that either show an increase (white), decrease (black), or no change (grey) in speed upon light activation for <i>Setd5</i><sup>+/+</sup> (top) and <i>Setd5</i><sup>+/<i>−</i></sup> (bottom). 0.01 mW mm<sup>−2</sup>: 35 trials, <i>p</i> = 0.649; 0.5 mW mm<sup>−2</sup>: 111 trials, <i>p</i> = 0.193; 5 mW mm<sup>−2</sup>: 50 trials, <i>p</i> < 0.001; 10 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001; 15 mW mm<sup>−2</sup>: 61 trials, <i>p</i> = 0.004; 20 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001, X<sup>2</sup> test of independence. …”
  5. 12905
  6. 12906
  7. 12907
  8. 12908

    Directed evolution of HIV-1 to utilize CD4<sup>low</sup> target cells. by David Beauparlant (3491435)

    Published 2017
    “…<b>(E)</b> Adaptation to CD4<sup>low</sup> target cells results in high resistance to CD4 inhibitor compared to wild type HIV-1 isolates. Comparison of IC50 of CD4-blocking DARPin 55.2 against 41 wild-type HIV-1 strains from different clades (black dots, see <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006255#ppat.1006255.s003" target="_blank">S3 Table</a> for details on virus panel and individual IC50 values) and the CD4<sup>low</sup> adaptation virus panel (colored dots, see legend) probed by Env pseudovirus infection on TZM-bl cells. …”
  9. 12909
  10. 12910
  11. 12911
  12. 12912
  13. 12913
  14. 12914

    Dysregulated alternative splicing in DM1 hiNeurons at 10 DPI. by Mougina K. Eltahir (12988153)

    Published 2022
    “…(d) Scatter plots pertaining to Fig 5c show decreased inclusion of <i>MAPT</i> e2 (top), <i>CSNK1D</i> e9 (bottom left) and <i>MPRIP</i> e9 (bottom right) in DM1 hiNeurons. …”
  15. 12915
  16. 12916

    Efficacy of R-LM113 and R-115 administered early after tumor implantation on the growth of HER2-LLC1 tumors. by Valerio Leoni (440542)

    Published 2018
    “…The mice decreased in number because of deaths caused by the primary tumor. …”
  17. 12917
  18. 12918
  19. 12919
  20. 12920